XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.3
LICENSE AND DISTRIBUTION AGREEMENTS (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 16, 2024
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2024
EUR (€)
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Jan. 24, 2022
USD ($)
LICENSE AGREEMENTS                          
Revenue   $ 2,261,642     $ 6,185,814     $ 11,139,956   $ 13,089,977      
Deferred revenue, current   13,130,509           13,130,509       $ 24,270,465  
Stock issued aggregate value   67,205,869 $ 1,985,849 $ 2,290,244 221,081 $ 2,130,395              
Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States                          
LICENSE AGREEMENTS                          
Potential milestone payments   90,000,000.0           90,000,000.0          
Milestone payments to be made upon completion of certain phases   10,000,000.0           10,000,000.0          
Upfront payment               30,000,000.0     $ 30,000,000.0    
Deferred revenue liability   1,100,000           1,100,000         $ 40,000,000.0
Revenue   2,300,000     $ 6,200,000     11,100,000   $ 13,100,000      
Deferred revenue, current   $ 1,100,000           $ 1,100,000          
Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01                          
LICENSE AGREEMENTS                          
Revenue, remaining performance obligation, expected timing of satisfaction, period   12 months           12 months          
Revenue, Remaining Performance Obligation, Percentage   100.00%           100.00%          
Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, Japan                          
LICENSE AGREEMENTS                          
Potential milestone payments             $ 89,000,000.0            
Upfront payment             $ 12,000,000.0            
Deferred revenue liability   $ 12,000,000.0           $ 12,000,000.0          
Deferred revenue, current   12,000,000.0           12,000,000.0          
Binding Term Sheet With Nippon Shinyaku Co Limited Europe                          
LICENSE AGREEMENTS                          
Upfront payment $ 20,000,000.0                        
Potential additional development and sales-based milestone payments $ 715,000,000.0                        
CSMC | Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States                          
LICENSE AGREEMENTS                          
Deferred revenue liability   40,000,000.0           $ 40,000,000.0          
Rome License Agreement                          
LICENSE AGREEMENTS                          
Notice period               90 days 90 days        
JHU License Agreement                          
LICENSE AGREEMENTS                          
Notice period               60 days 60 days        
Threshold period to cure breach               30 days 30 days        
CSMC License Agreement                          
LICENSE AGREEMENTS                          
Notice period               90 days 90 days        
Exosomes License Agreement                          
LICENSE AGREEMENTS                          
Notice period               90 days 90 days        
Minimum | Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States                          
LICENSE AGREEMENTS                          
Share of product revenue (in percent)                         30.00%
Minimum | Rome License Agreement                          
LICENSE AGREEMENTS                          
Minimum annual royalty payments | €                 € 20,000        
Maximum | Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States                          
LICENSE AGREEMENTS                          
Potential milestone payments                         $ 605,000,000.0
Share of product revenue (in percent)                         50.00%
Maximum | JHU License Agreement                          
LICENSE AGREEMENTS                          
Potential milestone payments   $ 1,850,000           $ 1,850,000          
Completion Of Phase Two Due | JHU License Agreement                          
LICENSE AGREEMENTS                          
Milestones paid                     250,000    
Milestone payments to be made upon completion of certain phases                     $ 500,000    
Patent rights | JHU License Agreement                          
LICENSE AGREEMENTS                          
Agreement effective period               20 years 20 years        
Non Payment of Royalties | CSMC License Agreement                          
LICENSE AGREEMENTS                          
Agreement termination period               30 days 30 days        
Non Payment of Royalties | Exosomes License Agreement                          
LICENSE AGREEMENTS                          
Threshold period to cure breach               30 days 30 days        
CSMC Agreement Compliance | CSMC License Agreement                          
LICENSE AGREEMENTS                          
Agreement termination period               90 days 90 days        
CSMC Agreement Compliance | Exosomes License Agreement                          
LICENSE AGREEMENTS                          
Threshold period to cure breach               90 days 90 days        
Material Breach Has Not Been Cured | CSMC License Agreement                          
LICENSE AGREEMENTS                          
Agreement termination period               90 days 90 days        
Material Breach Has Not Been Cured | Exosomes License Agreement                          
LICENSE AGREEMENTS                          
Threshold period to cure breach               90 days 90 days        
Fails To Cure Breach after Notice From CSMC | CSMC License Agreement                          
LICENSE AGREEMENTS                          
Agreement termination period               90 days 90 days        
Fails To Cure Breach after Notice From CSMC | Exosomes License Agreement                          
LICENSE AGREEMENTS                          
Threshold period to cure breach               90 days 90 days